Compare, Analyse CORAL LAB. with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CORAL LAB.   MYLAN
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
MYLAN
Dec-18
CORAL LAB./
MYLAN
5-Yr Chart
Click to enlarge
High Rs4433,575-   
Low Rs951,968-   
Sales per share (Unadj.) Rs270.51,645.1-  
Earnings per share (Unadj.) Rs38.044.7-  
Cash flow per share (Unadj.) Rs43.5352.7-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs382.81,779.7-  
Shares outstanding (eoy) m3.57514.50-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.01.7 59.1%   
Avg P/E ratio x7.162.0 11.4%  
P/CF ratio (eoy) x6.27.9 78.8%  
Price / Book Value ratio x0.71.6 45.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m9621,425,967 0.1%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1020-   
Avg. sales/employee Rs ThNM24,183.3-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM656.7-  
INCOME DATA
Net Sales Rs m966846,415 0.1%  
Other income Rs m380-   
Total revenues Rs m1,003846,415 0.1%   
Gross profit Rs m161219,021 0.1%  
Depreciation Rs m20158,482 0.0%   
Interest Rs m340,710 0.0%   
Profit before tax Rs m17619,829 0.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m41-3,155 -1.3%   
Profit after tax Rs m13622,984 0.6%  
Gross profit margin %16.725.9 64.5%  
Effective tax rate %23.0-15.9 -144.8%   
Net profit margin %14.02.7 516.9%  
BALANCE SHEET DATA
Current assets Rs m1,108472,637 0.2%   
Current liabilities Rs m278344,605 0.1%   
Net working cap to sales %86.015.1 568.6%  
Current ratio x4.01.4 290.9%  
Inventory Days Days13584 161.8%  
Debtors Days Days1,48093 1,586.2%  
Net fixed assets Rs m567164,190 0.3%   
Share capital Rs m36451 7.9%   
"Free" reserves Rs m1,3310-   
Net worth Rs m1,366915,666 0.1%   
Long term debt Rs m0988,297 0.0%   
Total assets Rs m1,6752,456,172 0.1%  
Interest coverage x63.21.5 4,252.2%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.60.3 167.3%   
Return on assets %8.32.6 318.5%  
Return on equity %9.92.5 395.2%  
Return on capital %13.13.2 411.9%  
Exports to sales %72.30-   
Imports to sales %2.00-   
Net fx Rs m6680-   
CASH FLOW
From Operations Rs m11175,885 0.0%  
From Investments Rs m-2-90,913 0.0%  
From Financial Activity Rs m3-81,937 -0.0%  
Net Cashflow Rs m121,457 0.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 75.11 Rs / USD

Compare CORAL LAB. With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CORAL LAB. With: IPCA LABS  GUFIC BIOSCIENCE  ALPA LAB  GANGA PHARMACEUTICALS  LAURUS LABS   



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views On News

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime (Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls (Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CORAL LAB. SHARE PRICE


Nov 26, 2021 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CORAL LAB.

CORAL LAB. - IPCA LABS COMPARISON

COMPARE CORAL LAB. WITH

MARKET STATS